| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retromer complex binding | 2.72e-05 | 10 | 124 | 3 | GO:1905394 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | STAM2 WASHC2C MARK1 RCSD1 WASHC2A AP2A2 PIK3C2A SVIL WDFY3 SNX1 | 2.84e-05 | 316 | 124 | 10 | GO:0035091 |
| GeneOntologyMolecularFunction | actin filament binding | 8.76e-05 | 227 | 124 | 8 | GO:0051015 | |
| GeneOntologyCellularComponent | WASH complex | 8.80e-05 | 15 | 124 | 3 | GO:0071203 | |
| Domain | CAP-ZIP_m | 2.86e-07 | 3 | 124 | 3 | PF15255 | |
| Domain | FAM21/CAPZIP | 2.86e-07 | 3 | 124 | 3 | IPR029341 | |
| Domain | AKAP6/CEP68 | 4.37e-05 | 2 | 124 | 2 | IPR026696 | |
| Domain | FAM21 | 4.37e-05 | 2 | 124 | 2 | IPR027308 | |
| Domain | TF_octamer | 1.31e-04 | 3 | 124 | 2 | IPR000972 | |
| Domain | DUF4704 | 4.32e-04 | 5 | 124 | 2 | IPR031570 | |
| Domain | DUF4704 | 4.32e-04 | 5 | 124 | 2 | PF15787 | |
| Domain | ARM-type_fold | 4.38e-04 | 339 | 124 | 9 | IPR016024 | |
| Domain | PH_BEACH | 6.45e-04 | 6 | 124 | 2 | PF14844 | |
| Domain | PH-BEACH_dom | 1.19e-03 | 8 | 124 | 2 | IPR023362 | |
| Domain | - | 1.19e-03 | 8 | 124 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.19e-03 | 8 | 124 | 2 | PS51783 | |
| Domain | SPEC | 1.23e-03 | 32 | 124 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.23e-03 | 32 | 124 | 3 | IPR018159 | |
| Domain | BEACH | 1.53e-03 | 9 | 124 | 2 | PS50197 | |
| Domain | Beach | 1.53e-03 | 9 | 124 | 2 | PF02138 | |
| Domain | - | 1.53e-03 | 9 | 124 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.53e-03 | 9 | 124 | 2 | SM01026 | |
| Domain | BEACH_dom | 1.53e-03 | 9 | 124 | 2 | IPR000409 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.60e-03 | 35 | 124 | 3 | IPR002464 | |
| Domain | Myosin_head_motor_dom | 2.03e-03 | 38 | 124 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.03e-03 | 38 | 124 | 3 | PS51456 | |
| Domain | DEAH_ATP_HELICASE | 2.03e-03 | 38 | 124 | 3 | PS00690 | |
| Domain | Myosin_head | 2.03e-03 | 38 | 124 | 3 | PF00063 | |
| Domain | MYSc | 2.03e-03 | 38 | 124 | 3 | SM00242 | |
| Domain | GDS_CDC24_CS | 2.19e-03 | 39 | 124 | 3 | IPR001331 | |
| Domain | - | 3.70e-03 | 95 | 124 | 4 | 2.60.120.200 | |
| Domain | PI3/4_kinase_CS | 4.34e-03 | 15 | 124 | 2 | IPR018936 | |
| Domain | POU | 4.94e-03 | 16 | 124 | 2 | SM00352 | |
| Domain | POU_dom | 4.94e-03 | 16 | 124 | 2 | IPR000327 | |
| Domain | - | 4.94e-03 | 16 | 124 | 2 | 1.10.1070.11 | |
| Domain | Pou | 4.94e-03 | 16 | 124 | 2 | PF00157 | |
| Domain | POU_1 | 4.94e-03 | 16 | 124 | 2 | PS00035 | |
| Domain | PI3Kc | 4.94e-03 | 16 | 124 | 2 | SM00146 | |
| Domain | POU_2 | 4.94e-03 | 16 | 124 | 2 | PS00465 | |
| Domain | POU_3 | 4.94e-03 | 16 | 124 | 2 | PS51179 | |
| Domain | POU | 5.57e-03 | 17 | 124 | 2 | IPR013847 | |
| Domain | Cytidine_deaminase-like | 5.57e-03 | 17 | 124 | 2 | IPR016193 | |
| Domain | DEXDc | 6.02e-03 | 109 | 124 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 6.22e-03 | 110 | 124 | 4 | IPR014001 | |
| Domain | UIM | 6.24e-03 | 18 | 124 | 2 | PF02809 | |
| Domain | PI3_PI4_kinase | 6.24e-03 | 18 | 124 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 6.24e-03 | 18 | 124 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.24e-03 | 18 | 124 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 6.24e-03 | 18 | 124 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 6.24e-03 | 18 | 124 | 2 | PS50290 | |
| Pubmed | AKAP6 SMG1 GNPTAB PSD3 ALS2 ADGRV1 CEP68 AP2A2 MACF1 WDFY3 OGA | 6.88e-10 | 225 | 126 | 11 | 12168954 | |
| Pubmed | WASHC2C PSD3 RAP1GAP2 ALS2 WASHC2A STARD9 ZNF644 SPHKAP DENND4B MACF1 ASXL2 SPEN USP33 | 3.30e-09 | 407 | 126 | 13 | 12693553 | |
| Pubmed | NES BRIP1 MOSPD2 TRIO ICE2 APC CHD1 WASHC2A PCDH17 STAT2 SF3A3 CEP295 ATIC USP1 CLUH USP33 | 1.07e-08 | 733 | 126 | 16 | 34672954 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MRPS31 HIVEP1 RAE1 MARK1 POLA1 APC USP37 TIMM8A WDR75 PIK3C2A SF3A3 ASXL2 LONRF2 OGA USP1 CA2 USP33 | 1.44e-07 | 1005 | 126 | 17 | 19615732 |
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 15778499 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES STAM2 HIVEP1 TRIO PSD3 APC ALS2 VPS13D PIK3C2A STARD9 SVIL TET1 OSBPL6 MACF1 WNK3 | 5.72e-07 | 861 | 126 | 15 | 36931259 |
| Pubmed | NES WASHC2C INTS7 NOC2L LRRC49 PSD3 APC WASHC2A NCOR2 SPHKAP LPIN2 WDFY3 OGA USP1 CA2 USP33 | 7.79e-07 | 1006 | 126 | 16 | 15226823 | |
| Pubmed | 1.38e-06 | 23 | 126 | 4 | 31748650 | ||
| Pubmed | Gene network analysis in a pediatric cohort identifies novel lung function genes. | 1.65e-06 | 24 | 126 | 4 | 24023788 | |
| Pubmed | 2.03e-06 | 102 | 126 | 6 | 11214970 | ||
| Pubmed | STAM2 TRIO MARK1 LRRC49 PSD3 GPRIN3 DENND4B MACF1 ADGRL2 SNX1 | 3.36e-06 | 421 | 126 | 10 | 36976175 | |
| Pubmed | 8.29e-06 | 130 | 126 | 6 | 12421765 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | STAM2 HIVEP1 WASHC2C RAE1 APC WASHC2A STAT2 NCOR2 ZNF644 MACF1 SPEN | 1.03e-05 | 588 | 126 | 11 | 38580884 |
| Pubmed | Human Oct-1L isoform has tissue-specific expression pattern similar to Oct-2. | 1.30e-05 | 2 | 126 | 2 | 12663137 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 11134019 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15831936 | ||
| Pubmed | Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. | 1.30e-05 | 2 | 126 | 2 | 11583619 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 31771949 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 20827171 | ||
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 1.30e-05 | 2 | 126 | 2 | 36717248 | |
| Pubmed | Identification of novel single-stranded DNA binding proteins recognizing octamer motif. | 1.30e-05 | 2 | 126 | 2 | 8185580 | |
| Pubmed | STAT2 Controls Colorectal Tumorigenesis and Resistance to Anti-Cancer Drugs. | 1.30e-05 | 2 | 126 | 2 | 38001683 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 12144930 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15847701 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 8156594 | ||
| Pubmed | MARK1 GNPTAB GPRIN3 USP37 CEP68 VPS13D AP2A2 CNTNAP4 MACF1 SPIDR | 1.33e-05 | 493 | 126 | 10 | 15368895 | |
| Pubmed | 1.42e-05 | 215 | 126 | 7 | 35973513 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MRPS31 LRRC8C MCPH1 POLA1 PCARE PCDH17 DENND4B FBXO43 CEP295 ATIC LONRF2 PLS1 | 1.59e-05 | 736 | 126 | 12 | 29676528 |
| Pubmed | 1.94e-05 | 151 | 126 | 6 | 17043677 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BRIP1 HIVEP1 WASHC2C POU2F1 NCOR2 MYO3A ZNF644 SVIL OGA SPEN CLUH UNC5D | 2.61e-05 | 774 | 126 | 12 | 15302935 |
| Pubmed | NES RAE1 NOC2L CWC27 ARHGEF11 WDR75 AP2A2 PIK3C2A SVIL MACF1 PLS1 | 2.99e-05 | 660 | 126 | 11 | 32780723 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.62e-05 | 341 | 126 | 8 | 32971831 | |
| Pubmed | The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. | 3.90e-05 | 3 | 126 | 2 | 2905684 | |
| Pubmed | Positive regulation of the vHNF1 promoter by the orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1. | 3.90e-05 | 3 | 126 | 2 | 8622679 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 10490647 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 24268649 | ||
| Pubmed | Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. | 3.90e-05 | 3 | 126 | 2 | 9584182 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 17442950 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 9823775 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 14729950 | ||
| Pubmed | OBF1 and Oct factors control the germinal center transcriptional program. | 3.90e-05 | 3 | 126 | 2 | 33512466 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 38254723 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 29531217 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 36764492 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 19710692 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 32003827 | ||
| Pubmed | The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. | 3.90e-05 | 3 | 126 | 2 | 8202368 | |
| Pubmed | Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2. | 3.90e-05 | 3 | 126 | 2 | 24367622 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 17234755 | ||
| Pubmed | 4.16e-05 | 105 | 126 | 5 | 23284306 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.44e-05 | 351 | 126 | 8 | 38297188 | |
| Pubmed | Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly. | 5.06e-05 | 20 | 126 | 3 | 32294449 | |
| Pubmed | 5.06e-05 | 20 | 126 | 3 | 21689717 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 6.16e-05 | 475 | 126 | 9 | 31040226 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RC3H2 CWC27 POLA1 ICE2 APC WASHC2A PIK3C2A KLHL7 MACF1 SPEN CLUH | 6.87e-05 | 724 | 126 | 11 | 36232890 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 7.77e-05 | 608 | 126 | 10 | 36089195 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 16129689 | ||
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 7720710 | ||
| Pubmed | Cloning and sequencing of POU-boxes expressed in mouse testis. | 7.78e-05 | 4 | 126 | 2 | 1970171 | |
| Pubmed | Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis. | 7.78e-05 | 4 | 126 | 2 | 26016715 | |
| Pubmed | POU homeodomain protein Oct-1 functions as a sensor for cyclic AMP. | 7.78e-05 | 4 | 126 | 2 | 19617623 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 9368058 | ||
| Pubmed | Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor. | 7.78e-05 | 4 | 126 | 2 | 15062576 | |
| Pubmed | Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. | 7.78e-05 | 4 | 126 | 2 | 9242494 | |
| Pubmed | Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy. | 7.78e-05 | 4 | 126 | 2 | 31059499 | |
| Pubmed | 7.94e-05 | 282 | 126 | 7 | 23667531 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 8.43e-05 | 495 | 126 | 9 | 27705803 | |
| Pubmed | 8.69e-05 | 497 | 126 | 9 | 23414517 | ||
| Pubmed | MRPS31 CYP2C9 MCM8 MTF2 POLA1 ICE2 GNPTAB POU2F1 CHD1 SLC15A2 SF3A3 MTBP ATIC OGA USP1 | 9.54e-05 | 1327 | 126 | 15 | 32694731 | |
| Pubmed | MRPS31 STAM2 MOSPD2 NOC2L PSD3 CHD1 WASHC2A WDR75 PIK3C2A ZNF644 MACF1 ADGRL2 OGA CLUH SNX1 USP33 | 9.77e-05 | 1487 | 126 | 16 | 33957083 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.06e-04 | 398 | 126 | 8 | 35016035 | |
| Pubmed | 1.19e-04 | 209 | 126 | 6 | 36779422 | ||
| Pubmed | Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. | 1.29e-04 | 5 | 126 | 2 | 17113391 | |
| Pubmed | Combinatorial roles of the nuclear receptor corepressor in transcription and development. | 1.29e-04 | 5 | 126 | 2 | 11030619 | |
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 12887926 | ||
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 16061936 | ||
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 34852225 | ||
| Pubmed | Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1. | 1.29e-04 | 5 | 126 | 2 | 11937630 | |
| Pubmed | The RNA helicase DHX34 functions as a scaffold for SMG1-mediated UPF1 phosphorylation. | 1.29e-04 | 5 | 126 | 2 | 26841701 | |
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 10536059 | ||
| Pubmed | The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. | 1.93e-04 | 6 | 126 | 2 | 25915022 | |
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 25279559 | ||
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 33205750 | ||
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 25308109 | ||
| Pubmed | Functional interaction between Oct-1 and retinoid X receptor. | 1.93e-04 | 6 | 126 | 2 | 10383413 | |
| Pubmed | 1.94e-04 | 31 | 126 | 3 | 19690177 | ||
| Pubmed | NES TRIO APC ARHGEF11 NCOR2 AP2A2 KLHL7 SPHKAP SVIL MACF1 WDFY3 WNK3 | 2.05e-04 | 963 | 126 | 12 | 28671696 | |
| Pubmed | HIVEP1 MCM8 MTF2 POU2F1 ANO5 ADAM28 AXDND1 PIK3C2A STARD9 SHOC1 | 2.07e-04 | 686 | 126 | 10 | 29987050 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MRPS31 HIVEP1 TRIO NOC2L POLA1 CHD1 WDR75 AP2A2 STARD9 SF3A3 SGO2 ATIC SPEN CLUH CA2 | 2.07e-04 | 1425 | 126 | 15 | 30948266 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.09e-04 | 232 | 126 | 6 | 25515538 | |
| Pubmed | 2.17e-04 | 332 | 126 | 7 | 37433992 | ||
| Pubmed | MRPS31 KCNH7 WASHC2C RAE1 TRIO MARK1 PSD3 APC WASHC2A AP2A2 SPHKAP MACF1 SNX1 | 2.61e-04 | 1139 | 126 | 13 | 36417873 | |
| Pubmed | 2.70e-04 | 7 | 126 | 2 | 29078383 | ||
| Pubmed | 2.70e-04 | 7 | 126 | 2 | 20937854 | ||
| Pubmed | 2.70e-04 | 7 | 126 | 2 | 11867749 | ||
| Pubmed | 2.90e-04 | 87 | 126 | 4 | 33798452 | ||
| Pubmed | 3.16e-04 | 89 | 126 | 4 | 36861887 | ||
| Pubmed | 3.37e-04 | 472 | 126 | 8 | 38943005 | ||
| Pubmed | 3.59e-04 | 8 | 126 | 2 | 11279128 | ||
| Pubmed | A FAM21-containing WASH complex regulates retromer-dependent sorting. | 3.59e-04 | 8 | 126 | 2 | 19922874 | |
| GeneFamily | WASH complex | 3.09e-04 | 6 | 83 | 2 | 1331 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 7.34e-04 | 9 | 83 | 2 | 1230 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AKAP6 SYCP2L MARK1 GNPTAB LRRC49 APC RAP1GAP2 POU2F1 POU2F2 GPRIN3 ANO5 PCDH17 PIEZO2 OSBPL6 CNTNAP4 LONRF2 SNX1 WNK3 | 5.26e-06 | 1106 | 125 | 18 | M39071 |
| Coexpression | EIF4E_DN | 8.62e-06 | 100 | 125 | 6 | M2790 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | LRRC8C STAM2 MOSPD2 MTF2 INTS7 STEAP4 POU2F1 WDR75 KLHL7 ZNF644 ETAA1 MTBP WDFY3 SPEN | 2.08e-05 | 776 | 125 | 14 | M1107 |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 2.16e-05 | 175 | 125 | 7 | M336 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | LRRC8C STAM2 MOSPD2 MTF2 INTS7 STEAP4 POU2F1 WDR75 KLHL7 ZNF644 ETAA1 MTBP WDFY3 SPEN | 2.68e-05 | 794 | 125 | 14 | MM982 |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 4.31e-05 | 195 | 125 | 7 | M13736 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | 5.06e-05 | 200 | 125 | 7 | M6542 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN | 5.06e-05 | 200 | 125 | 7 | M3891 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MRPS31 MOSPD2 CWC27 ICE2 GNPTAB APC CHD1 ZNF354B PIEZO2 ZNF644 ETAA1 USP1 | 7.33e-05 | 656 | 125 | 12 | M18979 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | MARK1 GNPTAB APC RAP1GAP2 POU2F1 POU2F2 OSBPL6 MED12L ZC3H12C LONRF2 | 8.08e-05 | 465 | 125 | 10 | M39066 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NES SYCP2L MCPH1 MCM8 POLA1 ICE2 LRRC49 APC POU2F1 CHD1 ADGRV1 TIMM8A ZNF644 TET1 ETAA1 MACF1 SGO2 MTBP CEP295 USP1 WNK3 CA2 | 3.50e-05 | 1459 | 124 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SMG1 BRIP1 MCM8 POLA1 ICE2 ALS2 USP37 WDR75 TET1 MED12L SGO2 CEP295 LONRF2 PLS1 WNK3 | 8.85e-05 | 820 | 124 | 15 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | SEMA4D BRIP1 MCM8 INTS7 POLA1 ALS2 USP37 WDR75 TET1 ETAA1 MED12L SGO2 LONRF2 PLS1 WNK3 | 9.10e-05 | 822 | 124 | 15 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | MCM8 POLA1 APC POU2F1 CHD1 MYO3A PIK3C2A TET1 ETAA1 SGO2 MTBP | 9.76e-05 | 469 | 124 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.09e-04 | 185 | 124 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MCPH1 MCM8 POLA1 ICE2 LRRC49 APC POU2F1 CHD1 TIMM8A ZNF644 TET1 ETAA1 MACF1 SGO2 MTBP CEP295 USP1 WNK3 CA2 | 1.24e-04 | 1257 | 124 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 1.49e-04 | 410 | 124 | 10 | GSM791122_500 | |
| CoexpressionAtlas | Stem Cells, SC.ST34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34+, Bone marrow, avg-2 | 1.52e-04 | 411 | 124 | 10 | GSM791112_500 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | SMG1 STAM2 NBEAL1 GNPTAB APC USP37 VPS13D PIK3C2A ZNF644 CEP295 ASXL2 | 5.51e-12 | 186 | 125 | 11 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.01e-08 | 191 | 125 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 9.99e-08 | 200 | 125 | 8 | 5c1b51b9571681d8b792d1443d9f8926dcd55b29 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.18e-07 | 164 | 125 | 7 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | remission-B_naive|World / disease stage, cell group and cell class | 8.42e-07 | 182 | 125 | 7 | cc1dfd2de35aee1a26f7efd78e108b60a3556ec5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-07 | 184 | 125 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-07 | 184 | 125 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-07 | 184 | 125 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.40e-07 | 185 | 125 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.08e-06 | 189 | 125 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.12e-06 | 190 | 125 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.12e-06 | 190 | 125 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.12e-06 | 190 | 125 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.20e-06 | 192 | 125 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.25e-06 | 193 | 125 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.34e-06 | 195 | 125 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 5.27e-06 | 156 | 125 | 6 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 5.27e-06 | 156 | 125 | 6 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.91e-06 | 171 | 125 | 6 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 9.52e-06 | 173 | 125 | 6 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.02e-05 | 175 | 125 | 6 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.02e-05 | 175 | 125 | 6 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-05 | 177 | 125 | 6 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 178 | 125 | 6 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 178 | 125 | 6 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.19e-05 | 180 | 125 | 6 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 183 | 125 | 6 | ba7753e9fe2a6a87c5264f299ac97da2ddbda178 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-05 | 183 | 125 | 6 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | remission-B_naive|remission / disease stage, cell group and cell class | 1.31e-05 | 183 | 125 | 6 | 280d55d67f1d44594206da2f3a332c9d799dbdf0 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.35e-05 | 184 | 125 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-05 | 185 | 125 | 6 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.44e-05 | 186 | 125 | 6 | f352c63666273defea3e57ba3a3bfad52c4ea65b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.44e-05 | 186 | 125 | 6 | e2d265003aaea1acaf618d3f102c9933c19102e6 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_B-B_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 1.44e-05 | 186 | 125 | 6 | 9d339f57036d17572882ebb801f2be9b1d1ddc1c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-05 | 186 | 125 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-05 | 187 | 125 | 6 | e7970ec1507adfa91a296489166142cb9400421f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-05 | 187 | 125 | 6 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 187 | 125 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.48e-05 | 187 | 125 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.53e-05 | 188 | 125 | 6 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 188 | 125 | 6 | 0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.53e-05 | 188 | 125 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-05 | 189 | 125 | 6 | 886dceacf96e2b6750c146a381da0bf96a2bb15b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-05 | 189 | 125 | 6 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-05 | 189 | 125 | 6 | 5f1f4321939877374a8ee13de93f2d1390af8e2e | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-05 | 190 | 125 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-05 | 190 | 125 | 6 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-05 | 190 | 125 | 6 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 190 | 125 | 6 | 7c402aa47f1bd7decacc366c1ed1a37e39b95c73 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.67e-05 | 191 | 125 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.67e-05 | 191 | 125 | 6 | b374676ac90572d65895052d46469906e2b6fd93 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-05 | 193 | 125 | 6 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | distal-Hematologic-B_cell-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.77e-05 | 193 | 125 | 6 | 202dc5ec2437602c15658074728c5f5aeeab0466 | |
| ToppCell | Dendritic_Cells|World / lung cells shred on cell class, cell subclass, sample id | 1.77e-05 | 193 | 125 | 6 | 7792eb6e247af2d7a8f80476f37dcd880922d625 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 1.82e-05 | 194 | 125 | 6 | 20967afbadb3cf80ba9f4d7ebda4e64389252e70 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-05 | 194 | 125 | 6 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-05 | 194 | 125 | 6 | ae6d5cf4c825b29e677296df2c0985431c83b82e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-05 | 194 | 125 | 6 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.88e-05 | 195 | 125 | 6 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | severe-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.88e-05 | 195 | 125 | 6 | 73e39005a597e13aea571ae6ae5824d1c7448b71 | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 1.93e-05 | 196 | 125 | 6 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.93e-05 | 196 | 125 | 6 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.93e-05 | 196 | 125 | 6 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | distal-2-Hematologic-B_cell|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.93e-05 | 196 | 125 | 6 | 2587b5d83fb4f1c4a69894aa0f5f7cb3898faa09 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.99e-05 | 197 | 125 | 6 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.99e-05 | 197 | 125 | 6 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-05 | 198 | 125 | 6 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.04e-05 | 198 | 125 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-05 | 198 | 125 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 2.04e-05 | 198 | 125 | 6 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | Transverse-(2)_B_cell-(23)_Follicular_B_cell|Transverse / shred on region, Cell_type, and subtype | 2.10e-05 | 199 | 125 | 6 | 9c49e114e17cdefc2651050fc3251e59ea251289 | |
| ToppCell | Transverse-B_cell-Follicular_B_cell|Transverse / Region, Cell class and subclass | 2.10e-05 | 199 | 125 | 6 | 1fa6e464fc929e721738e175389b85018c5e975f | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.16e-05 | 200 | 125 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.16e-05 | 200 | 125 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | 46f9c28b24e39acdf0481a02b6eb86ecdd83c504 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.96e-05 | 127 | 125 | 5 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 133 | 125 | 5 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 155 | 125 | 5 | 62b59cb32b12bd55b19e98786a866d788fc9e4bf | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.65e-05 | 155 | 125 | 5 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.37e-05 | 158 | 125 | 5 | 121d63b8e2e37107467b170e5b2c798a7dbf6325 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.63e-05 | 159 | 125 | 5 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.63e-05 | 159 | 125 | 5 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.88e-05 | 160 | 125 | 5 | bc4a93dc5f37829799c37877e751ff3bc122e4ab | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.15e-05 | 161 | 125 | 5 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.98e-05 | 164 | 125 | 5 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.98e-05 | 164 | 125 | 5 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 165 | 125 | 5 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-04 | 165 | 125 | 5 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | Dendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.06e-04 | 166 | 125 | 5 | fbeb74b98b58085de323f744b18d4a8f7b22d5d4 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 1.06e-04 | 166 | 125 | 5 | a853005a5587d42daecdf2e23a93109919021a4f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 169 | 125 | 5 | b2fdf9f842dc7c181bc951a8a6932c916ed835ef | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | 2d3618f78484bd3508b7bdae3a0d0183cdae5057 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 169 | 125 | 5 | 2322f03a115c662f808ebfc892192b7d38d48181 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 169 | 125 | 5 | 813472d429c0b12580b17b440e00a6d8beb7947f | |
| ToppCell | B_cell|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-04 | 170 | 125 | 5 | cec4090ba6a9c934d5f6f9e4aa7823f3713319b7 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 170 | 125 | 5 | f08aa6168ff0c20b2083dbf588dd3294e3d9580e | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.18e-04 | 170 | 125 | 5 | 53e9372cb06a2dc5c8ecb3f9af42f3c23da96431 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 171 | 125 | 5 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.21e-04 | 171 | 125 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.21e-04 | 171 | 125 | 5 | f4321133190a3df9d31f5d4021a464d3840145f1 | |
| Disease | immune system disease (implicated_via_orthology) | 5.07e-05 | 3 | 122 | 2 | DOID:2914 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 7.06e-05 | 243 | 122 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | maximal midexpiratory flow rate | 7.47e-05 | 20 | 122 | 3 | EFO_0004313 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.56e-04 | 276 | 122 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.89e-04 | 127 | 122 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.89e-04 | 200 | 122 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | cognitive function measurement | AKAP6 SEMA4D KCNH7 HIVEP1 CNMD PSD3 NKIRAS1 PCDH17 TIMM8A MYO3A MED12L CNTNAP4 ASXL2 ATIC LONRF2 OGA | 2.84e-04 | 1434 | 122 | 16 | EFO_0008354 |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 4.08e-04 | 150 | 122 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 4.67e-04 | 8 | 122 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.90e-04 | 239 | 122 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | protein CREG1 measurement | 5.99e-04 | 9 | 122 | 2 | EFO_0801937 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 6.62e-04 | 95 | 122 | 4 | EFO_0803331 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 8.24e-04 | 264 | 122 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | cholesteryl ester 24:5 measurement | 1.09e-03 | 12 | 122 | 2 | EFO_0021448 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 1.35e-03 | 115 | 122 | 4 | EFO_0007878, EFO_0010724 | |
| Disease | metabolic syndrome | 1.49e-03 | 200 | 122 | 5 | EFO_0000195 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.63e-03 | 121 | 122 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | response to olanzapine | 1.72e-03 | 15 | 122 | 2 | GO_0097333 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 1.72e-03 | 15 | 122 | 2 | C2930967 | |
| Disease | creatine kinase measurement | 1.89e-03 | 59 | 122 | 3 | EFO_0004534 | |
| Disease | docosahexaenoic acid measurement | 1.94e-03 | 127 | 122 | 4 | EFO_0007761 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 1.96e-03 | 16 | 122 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.34e-03 | 222 | 122 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.48e-03 | 225 | 122 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.49e-03 | 566 | 122 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.63e-03 | 447 | 122 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 2.63e-03 | 447 | 122 | 7 | C3714756 | |
| Disease | ovulation | 2.77e-03 | 19 | 122 | 2 | GO_0030728 | |
| Disease | opioid dependence | 3.10e-03 | 237 | 122 | 5 | EFO_0005611 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 3.61e-03 | 74 | 122 | 3 | EFO_0022280 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.65e-03 | 355 | 122 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.71e-03 | 152 | 122 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Ovarian Serous Adenocarcinoma | 4.05e-03 | 23 | 122 | 2 | C1335177 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 4.13e-03 | 364 | 122 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSIPLKNLTFNSSAV | 811 | P40145 | |
| ESDASLKQVKSFLTP | 496 | Q75V66 | |
| LKQVKSFLTPQITTS | 501 | Q75V66 | |
| QFKSKLTQAIAETPE | 391 | Q6UX04 | |
| EKTKLSSSEEFPQTL | 121 | Q76N32 | |
| DKIKITPNASFTLEN | 261 | Q9UKQ2 | |
| EQFTLISSTPQEKTK | 981 | Q96Q42 | |
| QLSATFPQLKSLETL | 1006 | P33076 | |
| NITDNSIPELEKSFK | 1791 | Q8WXG9 | |
| SDSKQTFSPVLKLNA | 1016 | O15085 | |
| FDQKSLSPIKDIISL | 196 | Q9C0A0 | |
| KSSPLIEKLQANLTF | 81 | Q6JBY9 | |
| NTLKPDSSRLENIKS | 1021 | O95490 | |
| LKKLLSFAENSTIPD | 276 | Q5W041 | |
| DFIQKITKTLPDANT | 211 | Q9BWV3 | |
| SSTPFNKEELSAILK | 956 | O14646 | |
| QSPESLKRKSSLTQE | 561 | Q76L83 | |
| ITTLAQKNPEEFKTS | 211 | O94973 | |
| LTKKESPLLTQETQT | 41 | Q9NRE1 | |
| NQKTPTSLTKLSLQD | 21 | Q9Y483 | |
| VQKPTKIDTSTLNLF | 2291 | Q6ZS30 | |
| TKLKTSEQLDQPISA | 306 | P78406 | |
| SIIDKLQSPESFAKS | 316 | Q9HBD1 | |
| PLNSTKSFAIKILDE | 451 | O14917 | |
| FQKLQSTSIKLALSP | 796 | Q9NVH2 | |
| DPATQKLITNIFSKE | 186 | Q9Y6F1 | |
| ALSSESIEKLPVFNK | 366 | Q16654 | |
| EKTQSKPFSIQELEL | 2021 | Q9Y618 | |
| KQETFPTLETVFTKL | 776 | Q86YW9 | |
| SSPQKFLSNLSKEEI | 286 | Q8NEM0 | |
| EKTTLQPTLKFTNNS | 206 | Q8N387 | |
| KRTSEQTPQFLLSTK | 46 | Q9UJA3 | |
| TFKETNQLKTKLPEN | 236 | Q3T906 | |
| SVESNFPKKLQSLLE | 861 | Q9Y6X6 | |
| KIPQLTLNFSEVKTE | 331 | Q9NS40 | |
| FTLLASKLSQPQSKS | 161 | Q9NYS0 | |
| VVPSLFKQKTSDELL | 471 | Q5H9U9 | |
| FQQLDLEKSVPSKKT | 6 | A6PVY3 | |
| KLTPFTISENLNLAL | 186 | Q14651 | |
| VTLPLKDFNLSKETV | 1661 | O00443 | |
| LESTLEKSLQAKFPS | 141 | Q32NB8 | |
| ALEKSFLANQKPTSE | 311 | P09086 | |
| KTSLSFQDPKLELQF | 321 | P48681 | |
| PISDFLSVTEKKLAN | 1591 | O94854 | |
| NKSATVELEKLQPSF | 2061 | O94854 | |
| QTSSLPEKNKVEFKL | 26 | Q8IUZ0 | |
| PLISKNFLSKTVQAE | 236 | Q8IXQ5 | |
| PFESSQKNTIALEKA | 96 | P57789 | |
| KKDLSLQRSPNSETE | 421 | Q1L5Z9 | |
| SSKPINFSVILKLSN | 496 | Q9Y3T9 | |
| SKDTKIQLQVPFSAT | 321 | Q9BZF3 | |
| KASPLTFTVQLSNKL | 1316 | P09884 | |
| KSFLENQKPTSEEIT | 396 | P14859 | |
| TNETLVIEKLSNKTP | 326 | Q9NY74 | |
| KTVKLNSPLEKINSF | 191 | Q9BX63 | |
| TFSLKNLSKTPALQL | 431 | Q4G163 | |
| FLPQKTFQSLSSKEI | 16 | Q9BRQ4 | |
| EILAKSSLLPSQFLQ | 351 | P62683 | |
| SNSDKPLIQDSDLKT | 496 | Q659A1 | |
| QPSTSTEKEKLIRFI | 871 | Q5T1B0 | |
| VQFLDKPILNSTSTL | 616 | Q6UWU2 | |
| LEQTFFSQVLPKTVK | 11 | Q9NSG2 | |
| FLQTKSLKVSNIPVT | 656 | Q9UI17 | |
| IDKTQLNPTSLQKLF | 91 | Q9P0L2 | |
| LAKLQSPIKEENTTA | 86 | Q9NS73 | |
| TNTLFQTEEKKLLSP | 496 | O75064 | |
| FNLKSLVDPKNLDTT | 456 | P11712 | |
| TSDAKTLLLNPKSQE | 556 | Q6ZVF9 | |
| QTDFLPSIEKTQKEL | 1466 | Q9C0D2 | |
| SPKEVATLSKELLQF | 976 | Q14147 | |
| ASVNKKTIPSNLLDE | 341 | Q9Y267 | |
| NSLLIESIKSFQKTP | 436 | Q16348 | |
| TIFDPSELQDLSSKK | 311 | O76082 | |
| NAAISLKFTPTETNK | 236 | P02748 | |
| TSNLNTDFLAKKIIP | 271 | Q96DY7 | |
| LKASLTKNFSILPSQ | 666 | A6NGG8 | |
| TKNFSILPSQDKSIL | 671 | A6NGG8 | |
| SFPVSPLTSNEKNLK | 271 | O43364 | |
| ESSKPNTLTLKDNAF | 446 | Q8NHP6 | |
| LPFDKQTTKSELLSQ | 166 | Q92665 | |
| IKTERSPENLTKNTA | 281 | Q2M3C7 | |
| VKKQELANSSDATLP | 26 | Q684P5 | |
| FNILTSNQKTLTPEK | 376 | P52630 | |
| LFNKLSQPVSKAIST | 821 | O95425 | |
| LDITFSNPKEVSTLK | 141 | O60502 | |
| VQSQAKDPDLKTLFT | 326 | Q8NE18 | |
| INTKLPSSFVEKLFI | 511 | Q96Q15 | |
| EITPTLKELKTQSQS | 3491 | Q96Q15 | |
| SNDTKIEIFLPTKVL | 391 | Q5VXU9 | |
| QSTTTLNKKDLPFVE | 1046 | Q562F6 | |
| TSSLNLPDKTLQFVK | 381 | Q92854 | |
| LQEENKVTQKFPSLS | 2286 | Q9P2P6 | |
| NSLSLFIPKSNSSKI | 1001 | Q8NFU7 | |
| QPNVLTKSLSKDSSF | 1316 | Q13023 | |
| LKEPISVSSEQVLKF | 211 | P00918 | |
| ILQKQSTFPQSSKDI | 1926 | P25054 | |
| DQPVKDNSFLSSKVL | 176 | O75829 | |
| SLVELLNQISPTFKK | 281 | O75153 | |
| NKNDFSPKVELATSL | 2261 | A4UGR9 | |
| FNKQTSPKILITTSD | 136 | Q9H9Y2 | |
| FTKNLSPDKINLSTL | 16 | A0JNW5 | |
| TLSQFAEKISKLPEV | 426 | Q8IZQ1 | |
| KLQVSQTEPAKSDLS | 916 | Q96T58 | |
| KVTTQTSLPLFRSKQ | 166 | Q13596 | |
| NQSLTSDEKLSELPK | 161 | Q14159 | |
| IFQLVSVKLPKSSSQ | 126 | Q8IWA0 | |
| KPKIVNQESLTESTS | 626 | Q5T4T6 | |
| SEIATDKLSFPLKNI | 2546 | Q9H5I5 | |
| VTQAILKKENPFSTS | 326 | Q687X5 | |
| QKDPQFSLISATIKS | 121 | O75886 | |
| DLFSSAKSQPLVQEK | 886 | Q9Y4E1 | |
| SNVVTKNKDLPESAL | 401 | P31939 | |
| ESSLFNPLSDIKVKV | 471 | Q6UXZ4 | |
| FQKNNTLTLPEELSK | 66 | Q9H582 | |
| DLFSSAKSQPLVQEK | 886 | Q641Q2 | |
| LQDNSFLSIDKVPSK | 76 | Q86T82 | |
| KSLESLDTSLFAKNP | 291 | Q12874 | |
| ILQDFKPEESQTTSK | 136 | Q9C0D7 | |
| SFTKPKVISLLQQGE | 56 | Q96LW1 | |
| NTVLKSTFPLKTEEQ | 501 | Q2TAA8 | |
| FTKNLSPDKINLSTL | 16 | Q6BDS2 | |
| PATTTKLSQEEQLKS | 921 | Q9NYI0 | |
| KDTQQLAFPSLKTTT | 1926 | P15822 | |
| LEQTQKSKPVFSESL | 81 | O60220 | |
| KVTEEKDFLNSLSPS | 756 | O94782 | |
| SVQDFKIPSNTTLKT | 146 | Q8TEY7 | |
| DSNKSSKSLQLDIIP | 1251 | O75962 | |
| PKNTSNKEISRDTLL | 906 | Q9BYP7 | |
| SIPQIKLSVFTSNKL | 3991 | Q5THJ4 | |
| LQVFQKSLPKATVES | 531 | Q92539 | |
| SLVNSQSLKSIPEKF | 206 | Q8TDW0 | |
| STKVFVKNPESLFLL | 671 | O00160 | |
| ENETSFKKTLEPTLS | 1276 | Q8NEV4 |